Table 2.
Impact of psoriasis, periodontitis, and tobacco use on the GCF levels of VEGF.
| Variables | VEGF-A | |
|---|---|---|
| Coef. ± SE | p | |
| Psoriasis | -21.91 ± 7.75 | 0.006 1 |
| Cons. | 77.26 ± 5.22 | 0.000 1 |
| F(1, 59) | 8.00 | |
| Prob>F | 0.006 | |
| Adjusted R2 | 0.105 | |
| Mild periodontitis | 3.30 ± 12.33 | 0.790 1 |
| Moderate periodontitis | 11.38 ± 12.33 | 0.280 1 |
| Severe periodontitis | 24.83 ± 10.92 | 0.027 1 |
| Cons. | 56.12 ± 7.37 | 0.000 1 |
| F(3, 57) | 1.90 | |
| Prob>F | 0.139 | |
| Adjusted R2 | 0.043 | |
| Psoriasis 2 | -23.40 ± 7.77 | 0.004 2 |
| Mild periodontitis 2 | -5.79 ± 11.97 | 0.631 2 |
| Moderate periodontitis | 9.54 ± 9.80 | 0.335 2 |
| Severe periodontitis | 21.56 ± 10.32 | 0.041 2 |
| Tobacco use | -9.58 ± 8.08 | 0.241 2 |
| Cons. | 74.15 ± 9.20 | 0.000 2 |
| F(5, 55) | 3.22 | |
| Prob>F | 0.013 | |
| Adjusted R2 | 0.156 | |
1Univariate linear regression models; 2Multivariate linear regression model; bold: p<0.05 (95% confidence interval). Coef., coefficient; SE, standard error; p, p-value. Number of observations = 61.